REALIZE
Phase 1 Recruiting
60 enrolled
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Phase NA Recruiting
400 enrolled
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
Phase NA Recruiting
40 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
Phase 1/2 Recruiting
70 enrolled
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
Phase 1 Recruiting
30 enrolled
EASE
Phase 2 Recruiting
100 enrolled
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
Phase 1/2 Recruiting
49 enrolled
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
Phase 2 Recruiting
39 enrolled
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
Phase 1/2 Recruiting
30 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
Phase 2 Recruiting
30 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/3 Recruiting
900 enrolled
HEME Home Transfusion Program
Phase NA Recruiting
700 enrolled
Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant
Phase 1 Recruiting
30 enrolled
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
Phase 2 Recruiting
20 enrolled
MYRACLE
Recruiting
1,400 enrolled
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Phase NA Recruiting
60 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
BAH2573
Phase 1/2 Recruiting
60 enrolled
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
Phase 1 Recruiting
18 enrolled
SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial
Phase 2 Recruiting
41 enrolled
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Phase 2 Recruiting
15 enrolled
Survivorship
Recruiting
45 enrolled
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
Phase 1/2 Recruiting
10 enrolled
PRONTO
Phase 2 Recruiting
100 enrolled
Myelofludate
Phase 1 Recruiting
35 enrolled
RATIONALISE
Phase 2/3 Recruiting
300 enrolled
Bergamo Lymphoid Cancer Registry
Recruiting
6,000 enrolled
ENROL
Recruiting
37,090 enrolled
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Phase 1/2 Recruiting
36 enrolled